Alixir Chem Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 7.00 Cr
as on 16-11-2024
- Company Age 5 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.26 Cr
as on 16-11-2024
- Revenue 96.70%
(FY 2023)
- Profit 336.53%
(FY 2023)
- Ebitda 85.11%
(FY 2023)
- Net Worth 3.84%
(FY 2023)
- Total Assets -33.62%
(FY 2023)
About Alixir Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹19.26 Cr.
Ajit Gujral, Kinjalben Patel, and Jigneshkumar Joshi serve as directors at the Company.
- CIN/LLPIN
U24239GJ2019PTC111416
- Company No.
111416
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Alixir Chem Private Limited offer?
Alixir Chem Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Ammonium Compound, Industrial Chemicals & Supplies, Water Coagulant.
Who are the key members and board of directors at Alixir Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Gujral  | Director | 06-Jul-2024 | Current |
| Kinjalben Patel | Director | 06-Jul-2024 | Current |
| Jigneshkumar Joshi | Director | 13-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Alixir Chem.
Alixir Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 96.7% increase. The company also saw a substantial improvement in profitability, with a 336.53% increase in profit. The company's net worth moved up by a moderate rise of 3.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alixir Chem?
In 2023, Alixir Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Sep 2024 | ₹19.00 Cr | Open |
Hdfc Bank Limited Creation Date: 12 Sep 2023 | ₹2.64 M | Open |
How Many Employees Work at Alixir Chem?
Unlock and access historical data on people associated with Alixir Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alixir Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alixir Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
